Use of cookies
Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy
Data on the direct treatment costs of diabetes are key for planning diabetes care.
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Indikatoren_ScreenreaderHinweis_Datentabelle
Direct costs for persons with diabetes are estimated at EUR 7.4 billion in 2020 (women: EUR 3.4 billion; men: EUR 4.0 billion). This equates to 1.7% of the total direct costs of all diseases (women: 1.4%; men: 2.1%). Both the direct costs of diabetes, as well as their proportion in relation to the direct costs of all diseases, are highest in the 45- to- 64-year (2.1%) and 65- to- 84-year age groups (2.3%). Compared to 2020, the direct costs for persons with diabetes in 2015 were lower with EUR 6.2 billion (women: EUR 3.0 billion, men: EUR 3.2 billion). In relation to total direct costs, the relative share of diabetes costs in 2015 (1.8%) and 2020 (1.7%) is comparable.
The direct costs of diabetes in 2020 were estimated by the Federal Statistical Office at EUR 7.4 billion (Destatis, 2022). With comorbidities and secondary diseases taken into account, estimates based on 2009 SHI data calculate that diabetes patients incurred at least EUR 21 billion more additional costs than people without diabetes (Jacobs et al., 2017, Köster et al., 2012).